Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema
ICD-10 E09.331 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema.
E09.331 refers to diabetes mellitus that is induced by drugs or chemicals, characterized by the presence of moderate nonproliferative diabetic retinopathy accompanied by macular edema. This condition arises when certain medications, such as glucocorticoids or antipsychotics, lead to insulin resistance or impaired insulin secretion, resulting in elevated blood glucose levels. The moderate nonproliferative diabetic retinopathy indicates that there are changes in the retina, such as microaneurysms and retinal hemorrhages, but without the severe complications seen in proliferative diabetic retinopathy. Macular edema, a common complication, occurs when fluid accumulates in the macula, leading to vision impairment. Management of this condition often involves controlling blood glucose levels through lifestyle modifications, oral hypoglycemics, or insulin therapy, while also addressing the ocular complications through regular ophthalmologic evaluations and potential treatments like laser therapy or intravitreal injections. Regular monitoring of HbA1c levels is crucial to assess long-term glycemic control and adjust treatment plans accordingly.
Detailed medication history, HbA1c levels, and treatment plans.
Patients presenting with elevated blood glucose levels after starting new medications.
Ensure clear documentation of the relationship between drug use and diabetes onset.
Comprehensive eye examination findings, including retinal imaging results.
Patients with diabetes presenting for routine eye exams or vision changes.
Document the severity of retinopathy and any treatments administered.
Used for follow-up visits for diabetes management.
Document patient's diabetes management plan and any changes in medication.
Endocrinology may require more detailed medication history.
Used when assessing diabetic retinopathy.
Detailed findings of the eye exam, including retinopathy assessment.
Ophthalmology must document the severity of retinopathy and any treatments.
Medications such as glucocorticoids, thiazide diuretics, and certain antipsychotics are known to induce diabetes by affecting insulin sensitivity or secretion.
Diabetic retinopathy is diagnosed through a comprehensive eye examination, including fundoscopic examination and retinal imaging to assess for changes such as microaneurysms and macular edema.
